Bone loss in adult offspring induced by low-dose exposure to teratogens

Journal of Bone and Mineral Metabolism

Volumn 30, Issue 3, 2012, Pages 270-280

  Torchinsky, Arkady ^a   Mizrahi, Limor ^a   Savion, Shoshana ^a   Shahar, Ron ^b   Toder, Vladimir ^a   Kobyliansky, Eugene ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bone loss; Developmental origins of health and disease; MicroRNAs; RANKL; Teratogens

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MICRORNA; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; EMBRYO; FEMALE; FEMUR; FETUS; GENE EXPRESSION; HINDLIMB; LIMB BUD; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; TERATOGENICITY; TRABECULAR BONE;

ACID PHOSPHATASE; AGING; ANIMALS; APOPTOSIS; AZACITIDINE; BONE RESORPTION; EMBRYO, MAMMALIAN; FEMALE; FEMUR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HINDLIMB; ISOENZYMES; LIMB BUDS; MICE; MICE, INBRED ICR; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANK LIGAND; REPRODUCTION; TERATOGENS; X-RAY MICROTOMOGRAPHY;

EID: 84863874032     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0311-7     Document Type: Article

References (47)

1. Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359:61-73
2. Winsloe C, Earl S, Dennison EM, Cooper C, Harvey NC (2009) Early life factors in the pathogenesis of osteoporosis. Curr Osteoporos Rep 7:140-144
3. Kung AW, Huang QY (2007) Genetic and environmental determinants of osteoporosis. J Musculoskelet Neuronal Interact 7:26-32 (Pubitemid 46730301)
4. Goodfellow LR, Earl S, Cooper C, Harvey NC (2010) Maternal diet, behaviour and offspring skeletal health. Int J Environ Res Public Health 7:1760-1772
5. Lanham SA, Roberts C, Perry MJ, Cooper C, Oreffo RO (2008) Intrauterine programming of bone. Part 2: alteration of skeletal structure. Osteoporos Int 19:157-167
6. Liang C, Oest ME, Prater MR (2009) Intrauterine exposure to high saturated fat diet elevates risk of adult-onset chronic diseases in C57BL/6 mice. Birth Defects Res B Dev Reprod Toxicol 86:377-384
7. Branch S, Francis BM, Brownie CF, Chernoff N (1996) Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss Webster mouse. Toxicology 112:37-43 (Pubitemid 26276039)
8. Maes C, Kobayashi T, Kronenberg HM (2007) A novel transgenic mouse model to study the osteoblast lineage in vivo. Ann N Y Acad Sci 1116:149-164 (Pubitemid 350274342)
9. Karsenty G (2003) The complexities of skeletal biology. Nature 423:316-318
10. Yirmiya R, Goshen I, Bajayo A, Kreisel T, Feldman S, Tam J, Trembovler V, Csernus V, Shohami E, Bab I (2006) Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci USA 103:16876-16881 (Pubitemid 44737346)
11. Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW (2004) Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23:2934-2949 (Pubitemid 38638854)
12. Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, McCorkell KA, Lakshman TV, Collins JE, Wachsberger P, Friedberg JS, Huebner K (2007) Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer 120:24-31 (Pubitemid 44901913)
13. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355
14. Zhang B, Wang Q, Pan X (2007) MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210:279-289 (Pubitemid 44956872)
15. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
16. Jensen ED, Gopalakrishnan R, Westendorf JJ (2010) Regulation of gene expression in osteoblasts. Biofactors 36:25-32
17. Zhao JJ, Sun DG, Wang J, Liu SR, Zhang CY, Zhu MX, Ma X (2008) Retinoic acid downregulates microRNAs to induce abnormal development of spinal cord in spina bifida rat model. Childs Nerv Syst 24:485-492 (Pubitemid 351330690)
18. Gueta K, Molotski N, Gerchikov N, Mor E, Savion S, Fein A, Toder V, Shomron N, Torchinsky A (2010) Teratogen-induced alterations in microRNA-34, microRNA-125b and microRNA-155 expression: correlation with embryonic p53 genotype and limb phenotype. BMC Dev Biol 10:20
19. Torchinsky A, Fein A, Toder V (1995) Immunoteratology: I. MHC involvement in the embryo response to teratogens in mice. Am J Reprod Immunol 34:288-298
20. Torchinsky A, Toder V, Carp H, Orenstein H, Fein A (1997) In vivo evidence for the existence of a threshold for hyperglycemia-induced major fetal malformations: relevance to the etiology of diabetic teratogenesis. Early Pregnancy 3:27-33
21. Ermakov S, Malkin I, Keter M, Kobyliansky E, Livshits G (2008) Family-based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD. Ann Hum Genet 72:510-518 (Pubitemid 351833748)
22. Molotski N, Savion S, Gerchikov N, Fein A, Toder V, Torchinsky A (2008) Teratogen-induced distortions in the classical NF-kappaB activation pathway: correlation with the ability of embryos to survive teratogenic stress. Toxicol Appl Pharmacol 229:197-205
23. Cao J, Venton L, Sakata T, Halloran BP (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18:270-277 (Pubitemid 36125919)
24. Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP (2005) Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res 20:1659-1668 (Pubitemid 41243554)
25. Judson R, Richard A, Dix DJ, Houck K, Martin M, Kavlock R, Dellarco V, Henry T, Holderman T, Sayre P, Tan S, Carpenter T, Smith E (2009) The toxicity data landscape for environmental chemicals. Environ Health Perspect 117:685-695
26. Shepard TH, Lemire RJ (2007) Catalog of teratogenic agents. Johns Hopkins University Press, Baltimore
27. Seeman E (2003) Bone quality. Osteoporos Int 14:S3-S7
28. Dempster DW (2003) Bone microarchitecture and strength. Osteoporos Int 14:S54-S56
29. Rubin CD (2005) Emerging concepts in osteoporosis and bone strength. Curr Med Res Opin 21:1049-1056
30. Griffith JF, Genant HK (2008) Bone mass and architecture determination: state of the art. Best Pract Res Clin Endocrinol Metab 22:737-764
31. Liang C, Oest ME, Jones JC, Prater MR (2009) Gestational high saturated fat diet alters C57BL/6 mouse perinatal skeletal formation. Birth Defects Res B Dev Reprod Toxicol 86:362-369
32. Lanham SA, Roberts C, Cooper C, Oreffo RO (2008) Intrauterine programming of bone. Part 1: alteration of the osteogenic environment. Osteoporos Int 19:147-156
33. Momparler RL (1985) Molecular, cellular and animal pharmacology of 5-aza-20-deoxycytidine. Pharmacol Ther 30:287-299
34. Momparler RL, Gonzales FA, Momparler LF, Ma A (1989) Preclinical evaluation of hematopoietic toxicity of antileukemic agent, 5-aza-20- deoxycytidine. Toxicology 57:329-336 (Pubitemid 19188280)
35. Cisneros FJ, Wilson R, Travlos G, Anderson LM, Branch S (2003) Susceptibility to postnatal growth retardation induced by 5-AZA-20-deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor 1. Life Sci 72:2887-2894 (Pubitemid 36410338)
36. Cisneros FJ, Branch S (2004) Transplacental exposure to the DNA demethylating agent, 5-AZA-CdR, affects the sexual behavior of CD-1 male mice. Neurotoxicology 25:411-417 (Pubitemid 38283545)
37. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110
38. Elefteriou F (2008) Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473:231-236
39. Rogers JM, Francis BM, Sulik KK, Alles AJ, Massaro EJ, Zucker RM, Elstein KH, Rosen MB, Chernoff N (1994) Cell death and cell cycle perturbation in the developmental toxicity of the demethylating agent, 5-aza-20-deoxycytidine. Teratology 50:332-339
40. Torchinsky A, Savion S, Gorivodsky M, Shepshelovich J, Zaslavsky Z, Fein A, Toder V (1995) Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis. Teratog Carcinog Mutagen 15:179-190 (Pubitemid 26078503)
41. Francis BM, Rogers JM, Sulik KK, Alles AJ, Elstein KH, Zucker RM, Massaro EJ, Rosen MB, Chernoff N (1990) Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity. Teratology 42:473-482 (Pubitemid 20383736)
42. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS (2008) A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 105:13906-13911
43. Schaap-Oziemlak AM, Raymakers RA, Bergevoet SM, Gilissen C, Jansen BJ, Adema GJ, Kogler G, le Sage C, Agami R, van der Reijden BA, Jansen JH (2009) MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev 19:877-885
44. Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423:349-355 (Pubitemid 40852710)
45. Itoh T, Nozawa Y, Akao Y (2009) MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse preosteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 284:19272-19279
46. Huang J, Zhao L, Xing L, Chen D (2010) MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28:357-364
47. O'Brien CA (2010) Control of RANKL gene expression. Bone 46:911-919